SEC Form 4 · accession 0000899866-15-000213
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Douglas Norby
Director
Period of report
Dec 11, 2015
Accepted (ET)
Dec 15, 2015 · 5:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share | Dec 11, 2015 | A | 13,000 | $18.01 | A | 45,481 | D | |
| Common Stock, par value $.0001 per share | Dec 11, 2015 | A | 12,276 | $16.83 | A | 57,757 | D | |
| Common Stock, par value $.0001 per share | Dec 11, 2015 | A | 7,932 | $26.64 | A | 65,689 | D | |
| Common Stock, par value $.0001 per share | Dec 11, 2015 | A | 5,572 | $49.43 | A | 71,261 | D | |
| Common Stock, par value $.0001 per share | Dec 11, 2015 | A | 3,237 | $85.75 | A | 74,498 | D | |
| Common Stock, par value $.0001 per share | Dec 11, 2015 | A | 3,425 | $96.35 | A | 77,923 | D | |
| Common Stock, par value $.0001 per shareF1 | Dec 11, 2015 | S | 34 | $186.97 | D | 77,889 | D | |
| Common Stock, par value $.0001 per shareF2 | Dec 11, 2015 | S | 35,575 | $187.57 | D | 42,314 | D | |
| Common Stock, par value $.0001 per shareF3 | Dec 11, 2015 | S | 9,833 | $188.24 | D | 32,481 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades through a broker-dealer at prices ranging from $186.00 - $186.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- F2This transaction was executed in multiple trades through a broker-dealer at prices ranging from $187.00 - $187.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- F3This transaction was executed in multiple trades through a broker-dealer at prices ranging from $188.00 - $188.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.